Cleared Traditional

ROCHE REAGENT FOR ALT (K924245) - FDA 510(k) Clearance

Class I Chemistry device.

K924245 · Roche Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1992
Decision
59d
Days
Class 1
Risk

K924245 is an FDA 510(k) clearance for the ROCHE REAGENT FOR ALT. Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Roche Diagnostic Systems, Inc. (Branchburg, US). The FDA issued a Cleared decision on October 22, 1992 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Roche Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K924245 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 1992
Decision Date October 22, 1992
Days to Decision 59 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 88d · This submission: 59d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 126
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K924245.
DIMENSION VISTA ALBUMIN, ALKALINE PHOSPHATASE, ASPARTATE AMINO TRANSFERASE, CARBAMAZEPINE & ALANINE AMINO TRANSFERASE
K061020 · Dade Behring, Inc. · May 2006
IL TEST ALT, PN 35311
K923623 · Instrumentation Laboratory CO · Sep 1992
PARAMAX ALANINE AMINOTRANSFERASE REAGENT
K901105 · Baxter Healthcare Corp · Mar 1990
COBAS READY STAT PROFILE REAGENT STRIP
K896234 · Roche Diagnostic Systems, Inc. · Feb 1990
ABBOTT ALT-ACTIVATED (LIQUID, LIST #01A55)
K890698 · Abbott Laboratories · Apr 1989
PYRIDOXAL-5-PHOSPHATE TABLETS
K874835 · Boehringer Mannheim Corp. · Jan 1988